Cargando…
Transplantation of MITO cells, mitochondria activated cardiac progenitor cells, to the ischemic myocardium of mouse enhances the therapeutic effect
Given the potential for myocardial stem cell transplantation as a promising treatment for heart failure, numerous clinical trials have been conducted and its usefulness has been clearly confirmed. However, the low rate of engraftment of transplanted cells has become a clinical problem, and this need...
Autores principales: | Sasaki, Daisuke, Abe, Jiro, Takeda, Atsuhito, Harashima, Hideyoshi, Yamada, Yuma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941106/ https://www.ncbi.nlm.nih.gov/pubmed/35318358 http://dx.doi.org/10.1038/s41598-022-08583-5 |
Ejemplares similares
-
Validation of Gene Therapy for Mutant Mitochondria by Delivering Mitochondrial RNA Using a MITO-Porter
por: Kawamura, Eriko, et al.
Publicado: (2020) -
Resveratrol-Encapsulated Mitochondria-Targeting Liposome Enhances Mitochondrial Respiratory Capacity in Myocardial Cells
por: Tsujioka, Takao, et al.
Publicado: (2021) -
Therapeutic Strategies for Regulating Mitochondrial Oxidative Stress
por: Yamada, Yuma, et al.
Publicado: (2020) -
An effective in vivo mitochondria-targeting nanocarrier combined with a π-extended porphyrin-type photosensitizer
por: Satrialdi,, et al.
Publicado: (2021) -
A system that delivers an antioxidant to mitochondria for the treatment of drug-induced liver injury
por: Hibino, Mitsue, et al.
Publicado: (2023)